BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11135708)

  • 1. Confined replication of a chimeric simian immunodeficiency virus.
    Takeda A; Nakamura H; Matano T
    Jpn J Infect Dis; 2000 Oct; 53(5):209-11. PubMed ID: 11135708
    [No Abstract]   [Full Text] [Related]  

  • 2. Narrowing down the critical region within env gene for determining neuropathogenicity of murine leukemia virus A8.
    Seki Y; Hirano N; Mizukura M; Watanabe R; Takase-Yoden S
    Microbiol Immunol; 2011 Oct; 55(10):694-703. PubMed ID: 21831205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhuman primate lentiviruses: models for human infection.
    Kodama T; Kestler HW; Burns DP; Ringler DJ; King NW; Daniel MD; Desrosiers RC
    Dev Biol Stand; 1990; 72():267-71. PubMed ID: 2282986
    [No Abstract]   [Full Text] [Related]  

  • 4. Unique sequence and lesional tropism of a new variant of neuropathogenic friend murine leukemia virus.
    Takase-Yoden S; Watanabe R
    Virology; 1997 Jul; 233(2):411-22. PubMed ID: 9217064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo.
    Pöhlmann S; Münch J; Aziz S; Reeves JD; Otto C; Leslie GJ; Hofmann H; Puffer BA; Baribaud F; Marzi A; Gramberg T; Chen Z; Stolte N; Haaft PT; Heeney JL; Stahl-Hennig C; Mätz-Rensing K; Schneider T; Doms RW; Kirchhoff F
    Virology; 2007 Apr; 360(2):275-85. PubMed ID: 17126374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric HIV-1 containing SIV matrix exhibit enhanced assembly in murine cells and replicate in a cell-type-dependent manner in human T cells.
    Chen P; Hübner W; Riviere K; Liu YX; Chen BK
    Virology; 2006 May; 349(1):1-12. PubMed ID: 16563454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo.
    Ott DE; Hewes SM; Alvord WG; Henderson LE; Arthur LO
    Virology; 1998 Apr; 243(2):283-92. PubMed ID: 9568028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.
    Maggiorella MT; Baroncelli S; Michelini Z; Fanales-Belasio E; Moretti S; Sernicola L; Cara A; Negri DR; Buttò S; Fiorelli V; Tripiciano A; Scoglio A; Caputo A; Borsetti A; Ridolfi B; Bona R; ten Haaft P; Macchia I; Leone P; Pavone-Cossut MR; Nappi F; Ciccozzi M; Heeney J; Titti F; Cafaro A; Ensoli B
    Vaccine; 2004 Sep; 22(25-26):3258-69. PubMed ID: 15308348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid change in gp41 is linked to the macrophage-only replication phenotype of a molecular clone of simian immunodeficiency virus derived from the brain of a macaque with neuropathogenic infection.
    Glenn AA; Novembre FJ
    Virology; 2004 Aug; 325(2):297-307. PubMed ID: 15246269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors.
    Nakaya Y; Nakaya T; Park MS; Cros J; Imanishi J; Palese P; García-Sastre A
    J Virol; 2004 Sep; 78(17):9366-75. PubMed ID: 15308731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domains in the simian immunodeficiency virus gp41 cytoplasmic tail required for envelope incorporation into particles.
    Celma CC; Manrique JM; Affranchino JL; Hunter E; González SA
    Virology; 2001 May; 283(2):253-61. PubMed ID: 11336550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
    Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV escape: there and back again.
    Altman JD; Feinberg MB
    Nat Med; 2004 Mar; 10(3):229-30. PubMed ID: 14991039
    [No Abstract]   [Full Text] [Related]  

  • 15. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys.
    Borsetti A; Baroncelli S; Maggiorella MT; Bellino S; Moretti S; Sernicola L; Belli R; Ridolfi B; Farcomeni S; Negri DR; Cafaro A; Ensoli B; Titti F
    Arch Virol; 2008; 153(3):463-72. PubMed ID: 18080858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
    Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
    J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a real-time quantitative reverse transcriptase PCR assay for detection of the Friend leukemia virus load in murine plasma.
    He JY; Cheng HJ; Wang YF; Zhu YT; Li GQ
    J Virol Methods; 2008 Feb; 147(2):345-50. PubMed ID: 18068233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
    Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y
    J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
    J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.